CompletedNot Applicable

Use of Intravitreal Triamcinolone and Retrobulbar Chlorpromazine as Alternatives to the Management of Painful Blind Eye

Brazil36 participantsStarted 2010-01

Plain-language summary

The purpose of this study is to evaluate the efficacy of intravitreal triamcinolone and retrobulbar chlorpromazine as alternatives in the management of ocular pain in blind eyes.

Who can participate

Age range15 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients treated in the period at HGCR who wanted to be part of the protocol by signing the consent form Exclusion Criteria: * patients whose follow-up period was less than three months

What they're measuring

Changes in Pain intensity

Timeframe: 0, 1 month, 3 months, 6 months after procedure

Trial details

NCT IDNCT01404364

SponsorHospital Governador Celso Ramos

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2010-12

View on ClinicalTrials.gov More Blind Painful Eye trials